Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
This study first suggests that Chi3l1 is a novel regulator of Th1/CTL responses and could be a target for treating cancer to increase tumor immunity.
PMID: 29699605 [PubMed - as supplied by publisher]
Source: BMB Reports - Category: Biochemistry Authors: Kim DH, Choi JM Tags: BMB Rep Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Melanoma | Skin Cancer | Study